Cartilage proteoglycan core protein gene expression during limb cartilage differentiation. 1986

R A Kosher, and S W Gay, and J R Kamanitz, and W M Kulyk, and B J Rodgers, and S Sai, and T Tanaka, and M L Tanzer

Changes in the steady-state cytoplasmic levels of mRNA for the core protein of the major sulfated proteoglycan of cartilage were examined during the course of limb chondrogenesis in vitro using cloned cDNA probes. Cytoplasmic core protein mRNA begins to accumulate at the onset of overt chondrogenesis in micromass culture coincident with the crucial condensation phase of the process, in which prechondrogenic mesenchymal cells become closely juxtaposed prior to depositing a cartilage matrix. The initiation of core protein mRNA accumulation coincides with a dramatic increase in the accumulation of mRNA for type II collagen, the other major constituent of hyaline cartilage matrix. Following condensation, there is a concomitant progressive increase in cytoplasmic core protein and type II collagen mRNA accumulation which parallels the progressive accumulation of cartilage matrix by the cells. The relative rate of accumulation of cytoplasmic type II collagen mRNA is greater than twice that of core protein mRNA during chondrogenesis in micromass culture. Cyclic AMP, an agent implicated in the regulation of chondrogenesis elicits a concomitant two- to fourfold increase in both cartilage core protein and type II collagen mRNA levels by limb mesenchymal cells. Core protein gene expression is more sensitive to cAMP than type II collagen gene expression. These results suggest that the cartilage proteoglycan core protein and type II collagen genes are coordinately regulated during the course of limb cartilage differentiation, although there are quantitative differences in the extent of expression of the two genes.

UI MeSH Term Description Entries
D011509 Proteoglycans Glycoproteins which have a very high polysaccharide content. Proteoglycan,Proteoglycan Type H
D002356 Cartilage A non-vascular form of connective tissue composed of CHONDROCYTES embedded in a matrix that includes CHONDROITIN SULFATE and various types of FIBRILLAR COLLAGEN. There are three major types: HYALINE CARTILAGE; FIBROCARTILAGE; and ELASTIC CARTILAGE. Cartilages
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002642 Chick Embryo The developmental entity of a fertilized chicken egg (ZYGOTE). The developmental process begins about 24 h before the egg is laid at the BLASTODISC, a small whitish spot on the surface of the EGG YOLK. After 21 days of incubation, the embryo is fully developed before hatching. Embryo, Chick,Chick Embryos,Embryos, Chick
D003094 Collagen A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH). Avicon,Avitene,Collagen Felt,Collagen Fleece,Collagenfleece,Collastat,Dermodress,Microfibril Collagen Hemostat,Pangen,Zyderm,alpha-Collagen,Collagen Hemostat, Microfibril,alpha Collagen
D003994 Bucladesine A cyclic nucleotide derivative that mimics the action of endogenous CYCLIC AMP and is capable of permeating the cell membrane. It has vasodilator properties and is used as a cardiac stimulant. (From Merck Index, 11th ed) Dibutyryl Adenosine-3',5'-Monophosphate,Dibutyryl Cyclic AMP,(But)(2) cAMP,Bucladesine, Barium (1:1) Salt,Bucladesine, Disodium Salt,Bucladesine, Monosodium Salt,Bucladesine, Sodium Salt,DBcAMP,Dibutyryl Adenosine 3,5 Monophosphate,N',O'-Dibutyryl-cAMP,N(6),0(2')-Dibutyryl Cyclic AMP,AMP, Dibutyryl Cyclic,Adenosine-3',5'-Monophosphate, Dibutyryl,Cyclic AMP, Dibutyryl,Dibutyryl Adenosine 3',5' Monophosphate,Disodium Salt Bucladesine,Monosodium Salt Bucladesine,N',O' Dibutyryl cAMP,Sodium Salt Bucladesine
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

R A Kosher, and S W Gay, and J R Kamanitz, and W M Kulyk, and B J Rodgers, and S Sai, and T Tanaka, and M L Tanzer
April 1988, Developmental biology,
R A Kosher, and S W Gay, and J R Kamanitz, and W M Kulyk, and B J Rodgers, and S Sai, and T Tanaka, and M L Tanzer
January 1982, Progress in clinical and biological research,
R A Kosher, and S W Gay, and J R Kamanitz, and W M Kulyk, and B J Rodgers, and S Sai, and T Tanaka, and M L Tanzer
July 1989, Development (Cambridge, England),
R A Kosher, and S W Gay, and J R Kamanitz, and W M Kulyk, and B J Rodgers, and S Sai, and T Tanaka, and M L Tanzer
November 1991, Matrix (Stuttgart, Germany),
R A Kosher, and S W Gay, and J R Kamanitz, and W M Kulyk, and B J Rodgers, and S Sai, and T Tanaka, and M L Tanzer
August 1991, Matrix (Stuttgart, Germany),
R A Kosher, and S W Gay, and J R Kamanitz, and W M Kulyk, and B J Rodgers, and S Sai, and T Tanaka, and M L Tanzer
September 1989, Development (Cambridge, England),
R A Kosher, and S W Gay, and J R Kamanitz, and W M Kulyk, and B J Rodgers, and S Sai, and T Tanaka, and M L Tanzer
January 1991, Biochemical and biophysical research communications,
R A Kosher, and S W Gay, and J R Kamanitz, and W M Kulyk, and B J Rodgers, and S Sai, and T Tanaka, and M L Tanzer
December 1995, Journal of molecular evolution,
R A Kosher, and S W Gay, and J R Kamanitz, and W M Kulyk, and B J Rodgers, and S Sai, and T Tanaka, and M L Tanzer
October 1988, The Journal of biological chemistry,
R A Kosher, and S W Gay, and J R Kamanitz, and W M Kulyk, and B J Rodgers, and S Sai, and T Tanaka, and M L Tanzer
November 1991, Differentiation; research in biological diversity,
Copied contents to your clipboard!